Abstract
Early tumour shrinkage (ETS), defined as a reduction of at least 20% in tumour size at first reassessment, has been recently investigated retrospectively in first-line trials of metastatic colorectal cancer (CRC), and appears to be associated with better outcomes. We have performed a systematic review and meta-analysis of published trials to evaluate the prognostic value of ETS in CRC in terms of overall survival (OS) and progression-free survival (PFS). An electronic search of the PubMed, SCOPUS, EMBASE, the Web of Science, and the Cochrane Central Register of Controlled Trial databases identified trials that compared outcomes of patients with or without ETS during first-line chemotherapy for metastatic CRC. The OS, reported as a hazard ratio (HR) with a 95% confidence interval (CI), was the primary outcome measure; the correlation coefficient (R) between ETS with median OS was also estimated. Twenty-one trials from 10 publications were analysed. Overall, patients with ETS were associated with a better OS (HR, 0.58; 95% CI, 0.53 to 0.64; P<0.00001) and PFS (HR, 0.57; 95% CI, 0.47-0.69; P<0.00001) compared with patients who were early non-responders. However, ETS was poorly correlated with OS in terms of surrogacy (R=0.37; 95% ...Continue Reading
References
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Jan 28, 1999·Statistics in Medicine·M K ParmarL Stewart
Sep 6, 2000·Lancet·M BuyseP Piedbois
Feb 3, 2006·Biometrical Journal. Biometrische Zeitschrift·José Cortiñas Abrahantes, Tomasz Burzykowski
Sep 19, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patricia A TangLillian L Siu
Sep 27, 2007·Journal of the National Cancer Institute·Theodore G KarrisonMark J Ratain
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marc BuysePascal Piedbois
Aug 13, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C SuzukiB Glimelius
Feb 22, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stéphane OudardCharles A Cuenod
Aug 18, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F Petrelli, S Barni
Dec 19, 2012·Acta Oncologica·Dominik P ModestVolker Heinemann
Mar 14, 2013·Cancer Science·Clemens GiessenVolker Heinemann
Sep 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hubert PiessevauxSabine Tejpar
Jan 15, 2014·Clinical Pharmacology and Therapeutics·R BrunoL Claret
Mar 22, 2014·The Oncologist·Maxime RonotSandrine Faivre
Apr 24, 2014·The Oncologist·Katherine M KrajewskiToni K Choueiri
Aug 5, 2014·The Lancet Oncology·Volker HeinemannSebastian Stintzing
Citations
Nov 18, 2015·Expert Opinion on Drug Metabolism & Toxicology·Louisa LoTimothy J Price
Apr 1, 2016·British Journal of Cancer·Toshikazu MoriwakiIchinosuke Hyodo
Mar 25, 2016·Expert Review of Anticancer Therapy·Timothy J PriceJeremy D Shapiro
May 22, 2016·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·R García-CarboneroF Matute
May 30, 2016·Mayo Clinic Proceedings·Chul Kim, Vinay Prasad
Aug 9, 2016·Medicine·Xiaobo HeHongyun Zhao
Sep 7, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Volker HeinemannJean-Yves Douillard
Oct 14, 2016·The Lancet Oncology·Michael Davidson, Ian Chau
Oct 22, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Mohamed BouchahdaUNKNOWN ARTBC International
Nov 7, 2016·BMC Cancer·Shahil Amin, Oliver F Bathe
Nov 20, 2016·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Chiara CremoliniM Di Maio
Nov 17, 2017·Metabolites·Jodi Rattner, Oliver F Bathe
Mar 14, 2018·British Journal of Cancer·Chiara CremoliniFilippo Pietrantonio
Jun 17, 2018·Cancer Science·Hiroki OsumiKensei Yamaguchi
Aug 12, 2018·International Journal of Cancer. Journal International Du Cancer·Nandita M deSouza, Clare M Tempany
Nov 28, 2017·ESMO Open·Kentaro SakamakiNarikazu Boku
Mar 25, 2019·Expert Opinion on Investigational Drugs·Ignacio MatosJosep Tabernero
Jul 4, 2019·JAMA Oncology·Filippo PietrantonioFilippo de Braud
Oct 10, 2018·World Journal of Surgical Oncology·Datian ChenHuiyu Wang
Jun 7, 2020·Journal for Immunotherapy of Cancer·Ashley M HopkinsMichael J Sorich
Jan 25, 2018·PloS One·Saman Maleki VarekiJames Koropatnick
Mar 7, 2020·World Journal of Clinical Oncology·Nuri Faruk Aykan, Tahsin Özatlı
Jan 18, 2020·International Journal of Clinical Oncology·Yosuke YoshidaMamoru Narukawa
Feb 2, 2019·European Radiology·Lola-Jade PalmieriJean-Baptiste Bachet
Feb 6, 2019·International Journal of Clinical Oncology·Giuseppe A CollocaDomenico Guarneri
Sep 21, 2019·JAMA Network Open·Tomasz BurzykowskiUNKNOWN Aide et Recherche en Cancerologie Digestive Group
Oct 31, 2017·Journal of Cancer Research and Clinical Oncology·Julien TaiebMarc Peeters
Dec 16, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Paolo MancaFilippo Pietrantonio
Apr 15, 2021·Journal for Immunotherapy of Cancer·Giovanni FucàFilippo Pietrantonio
Jun 17, 2021·Academic Radiology·Haidara AlmansourAhmed E Othman
Jul 1, 2021·Cancer Medicine·Riad SalemRiccardo Lencioni
Nov 16, 2021·Frontiers in Oncology·Alessandro ParisiGiampiero Porzio